Tag: zuranolone

Sage Therapeutics, Biogen get ZURZUVAE FDA approval for postpartum depression treatment

Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAE (zuranolone) 50 mg for adults ... Read More